Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19976 - 20000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	FAM83D	81610	downregulated	cupric oxide results in decreased expression of FAM83D mRNA	20q11.23	A21783
Cupric oxide	Approved	FBXL19	54620	upregulated	cupric oxide results in increased expression of FBXL19 mRNA	16p11.2	A21783
Cupric oxide	Approved	FBXL4	26235	downregulated	cupric oxide results in decreased expression of FBXL4 mRNA	6q16.1-q16.2	A21783
Cupric oxide	Approved	FBXO5	26271	downregulated	cupric oxide results in decreased expression of FBXO5 mRNA	6q25.2	A21783
Cupric oxide	Approved	FKBP7	51661	downregulated	cupric oxide results in decreased expression of FKBP7 mRNA	2q31.2	A21783
Cupric oxide	Approved	FOS	2353	upregulated	cupric oxide results in increased expression of FOS mRNA	14q24.3	A21783
Cupric oxide	Approved	FOSB	2354	upregulated	cupric oxide results in increased expression of FOSB mRNA	19q13.32	A21783
Cupric oxide	Approved	FOXF2	2295	downregulated	cupric oxide results in decreased expression of FOXF2 mRNA	6p25.3	A21783
Cupric oxide	Approved	FOXN3	1112	upregulated	cupric oxide results in increased expression of FOXN3 mRNA	14q31.3-q32.11	A21783
Cupric oxide	Approved	FSD1L	83856	upregulated	cupric oxide results in increased expression of FSD1L mRNA	9q31.2	A21783
Cupric oxide	Approved	G0S2	50486	downregulated	cupric oxide results in decreased expression of G0S2 mRNA	1q32.2	A21783
Cupric oxide	Approved	GABARAPL1	23710	upregulated	cupric oxide results in increased expression of GABARAPL1 mRNA	12p13.2	A21783
Cupric oxide	Approved	GABPA	2551	upregulated	cupric oxide results in increased expression of GABPA mRNA	21q21.3	A21783
Cupric oxide	Approved	GADD45B	4616	upregulated	cupric oxide results in increased expression of GADD45B mRNA	19p13.3	A21783
Cupric oxide	Approved	GADD45G	10912	upregulated	cupric oxide results in increased expression of GADD45G mRNA	9q22.2	A21783
Cupric oxide	Approved	GCLM	2730	upregulated	cupric oxide results in increased expression of GCLM mRNA	1p22.1	A21781
Cupric oxide	Approved	GCNA	93953	upregulated	cupric oxide results in increased expression of GCNA mRNA	Xq13.1	A21783
Cupric oxide	Approved	GDF15	9518	upregulated	cupric oxide results in increased expression of GDF15 mRNA	19p13.11	A21783
Cupric oxide	Approved	GEM	2669	upregulated	cupric oxide results in increased expression of GEM mRNA	8q22.1	A21783
Cupric oxide	Approved	GEMIN5	25929	downregulated	cupric oxide results in decreased expression of GEMIN5 mRNA	5q33.2	A21783
Cupric oxide	Approved	GPSM2	29899	downregulated	cupric oxide results in decreased expression of GPSM2 mRNA	1p13.3	A21783
Cupric oxide	Approved	GRN	2896	upregulated	cupric oxide results in increased expression of GRN mRNA	17q21.31	A21783
Cupric oxide	Approved	GTF2B	2959	upregulated	cupric oxide results in increased expression of GTF2B mRNA	1p22.2	A21783
Cupric oxide	Approved	GTSE1	51512	downregulated	cupric oxide results in decreased expression of GTSE1 mRNA	22q13.31	A21783
Cupric oxide	Approved	H1FX	8971	downregulated	cupric oxide results in decreased expression of H1FX mRNA	3q21.3	A21783

Displaying entries 19976 - 20000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability